| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |